Sanctuary Advisors’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$706K Buy
5,300
+3,053
+136% +$346K ﹤0.01% 1712
2026
Q1
$250K Buy
2,247
+36
+2% +$4.26K ﹤0.01% 2209
2025
Q4
$298K Buy
+2,211
New +$241K ﹤0.01% 2019

Other funds holding ABVX

Sanctuary Advisors's ABVX Position: Q2 2026 in Review

Sanctuary Advisors increased its Abivax (ABVX) stake by 136% in Q2 2026, buying an estimated $346K and bringing the position to 5,300 shares worth $706K. The position accounts for ﹤0.01% of the portfolio, ranked #1712.

Sanctuary Advisors first reported a position in ABVX in Q4 2025 and has held it in 3 quarters since. 304 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Sanctuary Advisors held 5,300 shares of Abivax worth $706K as of Q2 2026.
  • Sanctuary Advisors bought 3,053 Abivax shares in Q2 2026, an estimated $346K.
  • Abivax made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #1712 holding.
  • Sanctuary Advisors first reported a position in Abivax in Q4 2025 and has held it in 3 quarters since.
  • 304 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.